Literature DB >> 10919618

Clinical comparison of two total ankle replacements.

T M Clough, S Jari.   

Abstract

We compared the outcome of the cemented Thompson Parkridge Richards (TPR) ankle prosthesis with that of the cementless Scandinavian Total Ankle Replacement (STAR) ankle prosthesis in a demographically similar group of patients. These were 14 consecutive arthroplasties in 12 rheumatoid arthritis patients, all operated on by the same surgeon. The status of all patients, five years or more after surgery, is known. The mean follow-up periods for the TPR group and the STAR group are 7.2 and 5.4 years respectively. Four of the six TPR tibial components became radiographically loose within two years of surgery. Two of these have been converted to fusions. The STAR prostheses remain satisfactory both clinically and radiographically at five years.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10919618     DOI: 10.1177/107110070002100703

Source DB:  PubMed          Journal:  Foot Ankle Int        ISSN: 1071-1007            Impact factor:   2.827


  4 in total

Review 1.  [Modern three-piece total ankle replacement. Frequency and causes of luxation and premature wear of the polyethylene bearing].

Authors:  A H Hoffmann; B Fink
Journal:  Orthopade       Date:  2007-10       Impact factor: 1.087

2.  [The HINTEGRA ankle: short- and mid-term results].

Authors:  B Hintermann; V Valderrabano; M Knupp; M Horisberger
Journal:  Orthopade       Date:  2006-05       Impact factor: 1.087

3.  Treatment of isolated ankle osteoarthritis with arthrodesis or the total ankle replacement: a comparison of early outcomes.

Authors:  Charles L Saltzman; Robert G Kadoko; Jin Soo Suh
Journal:  Clin Orthop Surg       Date:  2010-02-04

Review 4.  The mid-term outcome of total ankle arthroplasty and ankle fusion in rheumatoid arthritis: a systematic review.

Authors:  Jacqueline van Heiningen; Thea P M Vliet Vlieland; Huub J L van der Heide
Journal:  BMC Musculoskelet Disord       Date:  2013-10-26       Impact factor: 2.362

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.